Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperazine SCHEMBL4732179 | 0.91 | LMNA (0.37) | CHRM2CHRM1LMNACYP3A4GABRA1 | |
| SCHEMBL62393 | 0.84 | KDM4E (0.32) | LMNAKDM4E | |
| SCHEMBL28080241 | 0.80 | CHRM2 (0.40) | CHRM2CHRM1CHRM5CHRM3KDM4E | |
| SCHEMBL28122578 | 0.79 | FDPS (0.34) | KDM4ESLC6A2ALDH1A1SMN1; SMN2 | |
| Water SCHEMBL28800260 | 0.79 | KDM4E (0.30) | KDM4E | |
| Sulfuric Acid SCHEMBL27952192 | 0.78 | CHRM2 (0.39) | CHRM2CHRM1LMNACYP3A4GABRA1 | |
| SCHEMBL28214258 | 0.78 | CHRM2 (0.36) | CHRM2CHRM1LMNACYP3A4GABRA1 | |
| SCHEMBL9172138 | 0.77 | LMNA (0.39) | CHRM2CHRM1LMNACYP3A4GABRA1 | |
| SCHEMBL987341 | 0.77 | SIGMAR1 (0.30) | SIGMAR1 | |
| SCHEMBL5047965 | 0.77 | FDPS (0.38) | TSHRKDM4ESLC6A2KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077092-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024118032-A1 | SPERM WASHING AND SPERM FREEZING SOLUTIONS ENRICHED WITH QUERCETIN | ISTANBUL MEDIPOL UNIVERSITESI TEKNOLOJI TRANSFER OFISI ANONIM SIRKETI (TR) | 2024-06-06 | — | — | WO | claimed |
| WO-2024057324-A1 | PLASMA-ACTIVATED COMPOSITIONS AND METHODS OF USE THEREOF | NOVA PLASMA LTD. (IL) | 2024-03-21 | — | — | WO | claimed |
| WO-2024047639-A1 | INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2024-03-07 | — | — | WO | claimed |
| WO-2023235132-A1 | CELL DELIVERY VEHICLE AND METHODS OF USING THE SAME | BLUEROCK THERAPEUTICS LP (US) | 2023-12-07 | — | — | WO | claimed |
| WO-2023225331-A1 | EXTENDED LIVE CELL BARCODING APPROACH FOR MULTIPLEXED MASS CYTOMETRY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-11-23 | — | — | WO | claimed |
| WO-2023212160-A1 | DRUG RELEASING HYDROGELS, MATERIALS, DEVICES, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2023-11-02 | — | — | WO | claimed |
| EP-4240322-A1 | RESPIRABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A POLYPEPTIDE FOR CORONA VIRUS TREATMENT AND NEUTRALIZATION | Masker Med Tech AB (SE) | 2023-09-13 | — | — | EP | claimed |
| EP-4189393-A1 | RELIABLE AND SCALABLE METHODS OF DETECTION AND PLATFORM FOR CONSUMER MEDICAL DEVICES | Simple Healthkit, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2023079301-A1 | ASSAYS USING MUTANT COMPLEMENT FACTOR I VARIANTS WITH DECREASED ACTIVITY | FREELINE THERAPEUTICS LIMITED (GB) | 2023-05-11 | — | — | WO | claimed |
| WO-2017132604-A1 | METHODS AND APPARATUS FOR DETECTING COMPOUNDS IN LIQUIDS | Undercover Colors, Inc. (US) | 2017-08-03 | — | — | WO | claimed |
| CN-106278524-A | The preparation method and applications of bio-feritlizer | 苏州益可泰电子材料有限公司 | 2017-01-04 | — | — | CN | claimed |
| WO-2015013177-A2 | RAPID DETECTION OF CARBAPENEMASE AND BETA-LACTAMASE PRODUCING BACTERIA | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2015-01-29 | — | — | WO | claimed |
| EP-2764099-A1 | ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF | Mitra Biotech Private Limited (IN) | 2014-08-13 | — | — | EP | claimed |
| WO-2013050962-A1 | ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF | MITRA BIOTECH PRIVATE LIMITED (IN) | 2013-04-11 | — | — | WO | claimed |
| WO-2010068759-A1 | PHARMACEUTICAL FORMULATIONS OF BIODEGRADABLE BIOCOMPATIBLE CAMPTOTHECIN-POLYMER CONJUGATES | MERSANA THERAPEUTICS, INC. (US) | 2010-06-17 | — | — | WO | claimed |
| EP-1067907-A1 | OCULAR IRRIGATING SOLUTION | UNIVERSITY OF BRISTOL (GB) | 2001-01-17 | — | — | EP | claimed |
| WO-1999051204-A1 | OCULAR IRRIGATING SOLUTION | UNIVERSITY OF BRISTOL (GB) | 1999-10-14 | — | — | WO | claimed |
| EP-0396584-A1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES. | HEALTH LAB SERVICE BOARD (GB) | 1990-11-14 | — | — | EP | claimed |
| WO-1989005356-A1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES | THE PUBLIC HEALTH LABORATORY SERVICE BOARD (GB) | 1989-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077092-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, MMP1 | CHRM2 4062/4885CHRM1 4306/4885LMNA 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.